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We applied multispacer typing (MST) by incorporating 
9 variable intergenic spacers to Bartonella henselae DNA 
detected in lymph node biopsy specimens from 70 patients 
with cat-scratch disease (CSD), in cardiac valve specimens 
from 2 patients with endocarditis, and in 3 human isolates 
from patients with bacillary angiomatosis, CSD, and endo-
carditis. Sixteen MST genotypes were found, 5 previously 
identiﬁ  ed in cats and 11 new. Of the studied DNA, 78.7% 
belonged to 2 genotypes, which were phylogenetically orga-
nized into 4 lineages. Human strains were mostly grouped 
within 2 lineages, previously identiﬁ   ed as Marseille and 
Houston-1. Our results suggest a greater genetic diversity 
in human-infecting B. henselae than what has previously 
been evaluated by using other genotyping methods. How-
ever, the diversity is not signiﬁ  cantly different from that of 
cat strains. MST is thus a suitable genotyping tool for evalu-
ating the genetic heterogeneity of B. henselae among iso-
lates obtained from human patients.
B
artonella henselae, ﬁ  rst identiﬁ  ed in 1990 and charac-
terized as a new species in 1992, is a gram-negative, 
fastidious bacterium associated with cats. B. henselae in-
fection in cats is usually asymptomatic, but infected cats 
may remain bacteremic for long periods, thus playing a ma-
jor role as a reservoir for the bacterium (1,2). Transmission 
of B. henselae among cats may be mediated by the cat ﬂ  ea, 
Ctenocephalides felis (3), and to humans by cat scratches 
or bites (4). B. henselae infection in humans exhibits a vari-
ety of clinical syndromes including the most common, cat-
scratch disease (CSD) (5), endocarditis (6), bacillary angi-
omatosis (7) and peliosis hepatis in immunocompromised 
patients (8), and other less frequent manifestations (9). B. 
henselae has also been detected in various domestic or wild 
animals, including dogs, lions, panthers, and cheetahs (10). 
More recently, B. henselae was detected in the porpoise, a 
marine mammal (11).
Because B. henselae has a complex and expanding host 
or reservoir system and has been associated with a rapidly 
increasing spectrum of clinical syndromes (12), epidemi-
ologic survey and exploration of population structure of 
this organism are critical. The following techniques have 
been used for this purpose: pulsed-ﬁ  eld gel electrophore-
sis (PFGE); restriction fragment length polymorphism; en-
terobacterial repetitive intergenic consensus (ERIC)–PCR; 
repetitive extragenic palindromic (REP)–PCR; infrequent 
restriction site (IRS)–PCR (10,13–18); DNA sequencing–
based approaches represented by sequences of 16S rDNA 
(19,20),  ftsZ ( 21),  gltA ( 22), 35-kDa protein–encoding 
(23), groEL, and pap31 genes (24); and the 16S-23S inter-
genic spacer (25). These investigations gradually offered 
insight into the population structure of B. henselae and 
allowed several genetic groups to be identiﬁ  ed. Initially, 
B. henselae isolates were classiﬁ  ed within 2 16S rRNA–
based genotypes, I and II, and 2 serotypes, Marseille and 
Houston-1 (20,23,26). Studies that used gltA, groEL, and 
pap31 gene sequence analysis, arbitrarily primed–PCR, 
ERIC-PCR, IRS-PCR, PFGE, or multilocus sequence typ-
ing (MLST) were congruent with serotypes, but not with 
genotype I and II classiﬁ  cation (13,22–24,27–29). Alto-
gether, B. henselae isolates were found to be distributed 
within 3 distinct lineages (Marseille, Houston-1, and Ber-
lin-2), and the 16S rRNA gene was not a sensitive marker 
of the clonal divisions of B. henselae. This suggested that 
a 16S rRNA recombination occurred in this species that 
may be facilitated by the coexistence of several strains in 
the blood of cats (27).
Several studies have suggested that human-associ-
ated isolates were less genetically heterogeneous than 
cat isolates (22,27,30), and a small group of cat isolates 
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were hypothesized to be the source of human infection 
(22,27). However, the limited discriminatory power of the 
available genotyping methods, with a maximum of only 7 
genotypes identiﬁ  ed (27), and the small number of human 
isolates studied prevented the population structure and the 
genetic relationship between cat and human isolates of B. 
henselae to be reliably investigated. Recently, we applied 
multispacer typing (MST), using 9 highly variable inter-
genic spacers, to 126 B. henselae cat isolates and identiﬁ  ed 
39 MST genotypes, which made it the highest resolution 
typing system (available from http://ifr48.timone.univ-
mrs.fr/mst_bhenselae/mst) (31). In this study, we applied 
MST, based on sequences from the 9 previously described 
variable intergenic spacers (31), to 75 human-infecting B. 
henselae isolates to evaluate their genetic diversity and 
compare it to that of cat isolates.
Materials and Methods
Study Design
We included in the study, when available, lymph node 
biopsy specimens and cardiac valve specimens from pa-
tients with a clinical diagnosis of CSD or endocarditis who 
had been referred to our laboratory from 2004 to 2006. All 
specimens were then frozen at –80°C for further culture and 
molecular detection of Bartonella species. B. henselae was 
detected by using PCR targeting the 16S-23S rRNA spac-
er (ITS) and pap31 gene (24,25). In addition, 3 human B. 
henselae isolates—type strain Houston-1, isolated from the 
blood of a patient with bacillary angiomatosis in USA; type 
strain Marseille, isolated from the lymph node biopsy speci-
men of a patient with CSD in France; and strain URBH-
TOIE49, isolated from the valve biopsy specimen of a pa-
tient with endocarditis in France (26)—were incorporated in 
this study. All B. henselae isolates and PCR amplicons were 
tested by MST by using 9 variable intergenic spacers named 
S1-S9, from the most to the least variable among cat isolates 
(31). When available, the 16S rRNA genotypes of studied 
strains were indicated (online Appendix Figure, available 
from www.cdc.gov/EID/content/13/8/1178-appG.htm).
Culture Conditions of B. henselae Human Isolates
B. henselae isolates were cultivated on blood agar 
(bioMérieux, Marcy l’Etoile, France) at 37°C in 5% CO2 
(Genbag CO2 System, bioMérieux). After a 5-day incu-
bation period, Bartonella cells were collected for DNA 
extraction.
DNA Preparation
Total genomic DNA was extracted from the 3 studied 
B. henselae isolates by using the Chelex procedure as previ-
ously described (32). For patients’ specimens, we used the 
QIAamp Tissue kit (QIAGEN, Hilden, Germany) to extract 
the total genomic DNA, as described by the manufacturer.
PCR Ampliﬁ  cation and Sequencing
ITS and pap31 gene PCR ampliﬁ  cations were per-
formed by using the previously described conditions and 
the 16SF-23S1 (25) and PAPn1-PAPn2 (24) primer pairs, 
respectively. For ampliﬁ  cation and sequencing of the 9 in-
tergenic spacers, we used the same primers as in our previ-
ous study (31), except for primers amplifying spacers S1 
and S8, which caused unspeciﬁ  c ampliﬁ  cations from DNA 
extracted from human specimens. One new set of primers 
was designed to amplify each of these 2 spacers, as indi-
cated in the online Appendix Table (available from www.
cdc.gov/EID/content/13/8/1178-appT.htm). 
These new primers also ampliﬁ  ed the whole intergenic 
spacers and thus did not affect genotype comparison be-
tween human and cat strains. All primers were obtained 
from Eurogentec (Seraing, Belgium). PCRs were performed 
in a PTC-200 automated thermal cycler (MJ Research, 
Waltham, MA, USA). One nanomolar concentration of 
each DNA preparation was ampliﬁ  ed in a 25-μL reaction 
mixture containing 50 pmol/L of each primer; 200 μmol/L 
(each) dATP, dCTP, dGTP, and dTTP (Invitrogen, Gaith-
ersburg, MD, USA); 1.5 U of HotstarTaq DNA polymerase 
(QIAGEN); 2.5 μL 10× PCR buffer; and 1 μL 25 mmol/L 
MgCl2. The following conditions were used for ampliﬁ  ca-
tion: an initial 15-min step at 95°C was followed by 40 cy-
cles of denaturation for 30 s at 94°C, annealing for 30 s at 
55°C, and extension for 1 min at 72°C. Final ampliﬁ  cation 
was completed by holding the reaction mixture for 5 min 
at 72°C to allow complete extension of the PCR products. 
PCR products were puriﬁ  ed by using the MultiScreen PCR 
ﬁ  lter plate (Millipore, Saint-Quentin-en-Yvelines, France) 
as recommended by the manufacturer. Amplicons were se-
quenced in both directions by using the BigDye 1.1 chem-
istry (Applied Biosystems, Foster City, CA, USA) on an 
ABI 3130XL automated sequencer (Applied Biosystems) 
as described by the manufacturer. To avoid contamination, 
no positive control was used. Sterile water was used as a 
negative control in each PCR. Sequences from each DNA 
sample were checked twice in both directions to ensure the 
reliability of the MST method.
Sequence Analysis
Nucleotide sequences were edited by using the Au-
toassembler package (PerkinElmer, Waltham, MA, USA). 
For each intergenic spacer, a genotype was deﬁ  ned as a se-
quence exhibiting unique mutations, which were checked 
by sequencing the corresponding spacers 3 times. MST 
genotypes were deﬁ  ned as unique combinations of the 9 
spacer genotypes.RESEARCH
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Phylogenetic Analysis
For the phylogenetic analysis, we concatenated se-
quences from the 9 studied spacers. We included in the 
analysis the 39 MST genotypes previously obtained from 
the MST analysis of cat isolates (31) and those, when dif-
ferent, obtained in the present study. Multiple alignment of 
sequences was carried out by using CLUSTALW software 
(33). Phylogenetic relationships were obtained by using the 
neighbor-joining and maximum parsimony methods within 
the MEGA 2.1 software (34), and the maximum likelihood 
method within the BioEdit software (available from www.
mbio.ncsu.edu/bioedit/bioedit.html).
Statistical Analysis
The genotypic diversities of human and cat strains of 
B. henselae were compared by using the Fisher exact test 
within the Epi Info 6.0 software (Centers for Disease Con-
trol and Prevention, Atlanta, GA, USA). A difference was 
considered statistically signiﬁ  cant when p<0.01.
Results
Genotypic Distribution of 75 B. henselae 
Strains Detected in Humans
From January 2004 to May 31, 2006, B. henselae 
was detected in 70 lymph node biopsy specimens from 
70 patients with CSD and 2 cardiac valve specimens from 
2 patients with endocarditis by using PCRs targeting the 
ITS and pap31 gene. Among the 72 B. henselae–positive 
samples, 71 were obtained from patients living in France, 
and the remaining specimen was from a cardiac valve bi-
opsy from a patient living in Guadeloupe Island in the West 
Indies. When applying MST to the 72 B. henselae ampli-
cons and the 3 studied isolates, we identiﬁ  ed the following 
number of types for the S1–S9 spacers: 3, 5, 3, 4, 3, 2, 3, 2, 
and 2 types, respectively (Table). For each of spacers S1, 
S2, S4, and S6, a new genotype, i.e., 10, 8, 6, and 5, respec-
tively, was identiﬁ  ed. For each spacer, differences among 
genotypes mainly consisted of nucleotide substitutions. 
Ranges of nucleotide similarity rates among tested strains 
were 98.5%–100% for spacer 1, 97.4%–99.7% for spacer 
2, 98.3%–99.7% for spacer 3, 99.1%–99.8% for spacer 
4, 98.9%–100% for spacer 5, 97.8%–99.7% for spacer 6, 
98.8%–99.6% for spacer 7, 98.3%–99.4% for spacer 8, 
and 97.6%–99.4% for spacer 9. Combining genotypes ob-
tained from the 9 spacers allowed the 75 studied human B. 
henselae strains to be classiﬁ  ed into 16 MST genotypes. Of 
these, 5 MST genotypes, including 64 strains, were previ-
ously known among cat isolates, i.e., types 5, 16, 22, 26, 
and 31 (online Appendix Figure). The remaining 11 MST 
genotypes, numbered types 40–50 including 1 human strain 
each, were new.
Sequences from the 4 new genotypes of spacers S1, 
S2, S4, and S6 and the 11 new MST genotypes were de-
posited in the GenBank database under accession nos. 
EF017703 (tRNA-Ala/GCA-tRNA-Ile/AUC spacer, type 
10), EF017704 (BH2865724-dut spacer, type 8), EF017705 
(pssA-Oxidoreductase spacer, type 6), and EF017706 (alr-
gcvP spacer, type 5). These sequences were then added to 
the MST Rick database.
Phylogenetic Analysis
Phylogenetic trees obtained by using alignment of the 
9 concatenated spacer sequences and the neighbor-joining, 
maximum parsimony, and maximum likelihood methods 
showed similar organizations. The 50 MST genotypes (in-
Table. Human-infecting Bartonella henselae included in this study and corresponding genotypes* 
No. patients by clinical condition  Genotypes 
CSD Endocarditis Bacillary angiomatosis  S1 S2 S3 S4 S5 S6 S7 S8 S9 MST
2 1 1 511122211 5
1 † 5211222111 6
3 7 3545222132 2
3 5115222112 6
1 5111224213 1
1 ‡ 3554151134 0
1 § 5611222114 1
1 5111524214 2
1 5811224214 3
1 5111224114 4
1 5515222114 5
1 5141222114 6
1 3141222134 7
1 3546222134 8
1 1 0 111222114 9
1 5254121115 0
*CSD, cat-scratch disease; MST, multispacer typing. 
†Marseille strain. 
‡Houston-1 strain. 
§URBHTOIE 49 strain. Genetic Diversity of Bartonella henselae
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cluding the 39 MST genotypes previously identiﬁ  ed among 
cat isolates [31] and the 11 new MST genotypes identiﬁ  ed 
in the present study) were grouped into 4 clusters (online 
Appendix Figure). Two clusters were associated with pre-
viously described Houston-1 and Marseille serotypes. Clus-
ter 1 was composed of 19 MST genotypes and contained 22 
American and all 19 Asian cat isolates, and only 1 amplicon 
detected in the cardiac valve of the patient with endocardi-
tis from Guadeloupe Island. Cluster 2 (Houston-1) com-
prised 6 MST genotypes and contained 17 European and 5 
American cat isolates as well as 39 amplicons, including 38 
from patients with CSD and type strain Houston-1. Cluster 
3 (Marseille) included 21 MST genotypes represented by 8 
European and 38 American cat isolates and 35 amplicons, 
including 33 from patients with CSD, 2 from patients with 
endocarditis. and type strain Marseille. Cluster 4 contained 
13 European and 4 American cat isolates but no human am-
plicon (online Appendix Figure).
Two genotypes (5, and 22,) were mainly found in the 
Houston-1 and Marseille clusters, respectively. Genotype 
22 contained 37 human strains or amplicons and 16 Eu-
ropean cat isolates; genotype 5 included 22 human am-
plicons, 7 European and 23 American cat isolates. The 3 
human strains from patients with endocarditis were classi-
ﬁ  ed within 3 different MST genotypes, i.e., genotypes 22, 
41, and 50. Type strain Houston-1, obtained from a patient 
with bacillary angiomatosis, exhibited the unique genotype 
50, whereas type strain Marseille shared genotype 16 with 
an American cat isolate (online Appendix Figure).
The genotypic diversity of human strains was not statis-
tically different from that of cat isolates (16/75 vs. 39/129, 
p = 0.3), even when restricted to French human strains or 
cat isolates (14/73 vs. 6/29, p = 0.9). However, when we 
compared the distribution of human strains among clusters, 
we found that the Houston-1 and Marseille clusters con-
tained signiﬁ  cantly more human strains than did cluster 1 
(p<0.01) and also that the Houston-1 cluster contained a 
signiﬁ  cantly higher proportion of human strains than the 
Marseille cluster (p<0.01).
In addition to type strains Houston-1 and Marseille, the 
16S rRNA genotype was known for 67 cat strains. Phylo-
genetic cluster 1 contained 18 type I strains; cluster Hous-
ton-1 contained 21 type I strains and 1 type II strain; and 
clusters Marseille and 4 contained 20 and 9 type II strains, 
respectively.
Discussion
We report the successful adaptation of MST to B. hense-
lae detected in human samples. Isolating B. henselae from 
CSD patients is extremely difﬁ  cult (35). In this context, a 
reliable and reproducible molecular typing method, using 
PCR coupled to sequencing, to study the genetic diversity 
of B. henselae detected in human specimens directly, is a 
valuable option. Recently, MLST that used 9 housekeeping 
genes classiﬁ  ed 20 cat and 17 human isolates into 7 types, 
with most of the 17 human isolates belonging to 1 speciﬁ  c 
genotype. That study suggested that human isolates were 
more homogenous than cat isolates. However, the study 
was limited by the small number of human isolates stud-
ied and the limited discriminatory power of MLST, which 
hindered in-depth exploration of the genotypic diversity of 
B. henselae (27). In our present study with MST, using 9 
highly variable ITS exhibiting a high resolution for subtyp-
ing B. henselae (31), we investigated the genetic diversity 
of B. henselae detected in humans.
When MST was previously applied to B. henselae 
cat isolates, we found 39 distinct genotypes, 4 of which 
(5, 2, 22, and 35) were predominant (31). We identiﬁ  ed 16 
MST genotypes among the 75 B. henselae human strains. 
Of these, 59 strains (78.7%) also belonged to genotypes 5 
and 22. We found no statistical difference in genotypic di-
versity between the 75 human strains (16 MST genotypes) 
and the 126 previously studied cat isolates (39 genotypes, 
p = 0.14) (31).
The addition of 11 new MST genotypes to the 39 pre-
viously identiﬁ  ed did not modify the phylogenetic distri-
bution of 4 main clusters (lineages) described among cat 
isolates (31). However, the human strains had a speciﬁ  c 
phylogenetic distribution. Clusters 1 and 4 contained sig-
niﬁ  cantly fewer human strains than did clusters Houston-1 
and Marseille (p<0.01). For cluster 1, this difference may 
be explained by the fact that this cluster contained only 
cat isolates from the United States and Asia, whereas we 
studied mostly human strains from France. The only human 
strain classiﬁ  ed within cluster 1 was detected in 1 patient 
from the West Indies, but we acknowledge that this single 
patient, although exhibiting a speciﬁ  c genotype, does not 
allow us to draw any conclusions about the distribution of 
B. henselae genotypes in this area. Therefore, estimating 
the MST genotypes of human strains from the West Indies, 
United States, and Asia and comparing them to MST geno-
types classiﬁ  ed within cluster 1 might be useful. Regard-
ing the distribution of strains within cluster 4 (4 cat strains 
from the United States, 10 cat strains from France, and 3 
cat strains from Germany, but no human strain), we specu-
late that these strains may be less pathogenic for humans or 
that a sampling bias occurred. Thus, additional human and 
cat B. henselae isolates or amplicons from more countries 
will be needed to investigate the geographic correlation be-
tween human and cat isolates.
Previously, on the basis of the polymorphisms of the 
pap31 gene, among 107 B. henselae human strains origi-
nated from France, Zeaiter et al. identiﬁ  ed 4 genotypes 
grouped into 2 lineages, Marseille, including genotypes 
Marseille and CAL-1, and Houston-1, including geno-
types Houston-1 and ZF-1; this remains the largest genetic RESEARCH
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study of B. henselae human strains (24). Of the 107 human 
strains, 63 and 40 hold genotypes CAL-1 and ZF-1, re-
spectively, which were predominant among French human 
strains (24). In our study, among 73 French human strains, 
14 MST genotypes were also identiﬁ  ed into 2 lineages, 
Houston-1, including 38 strains of 2 genotypes, and lineage 
Marseille, including 35 strains of 12 genotypes; genotypes 
22 and 5 within lineages Houston-1 and Marseille, respec-
tively, contained 37 and 22 human strains and were pre-
dominant. Thus, the phylogenetic relationships of French 
human strains identiﬁ  ed by pap31 were similar to what 
was found by using MST, although MST was more dis-
criminatory than pap31-typing (p<0.01). However, MLST 
based on 9 genes later identiﬁ  ed 7 genotypes and 3 lineages 
(Marseille, Houston-1, and Berlin-2) among 20 cat and 17 
human isolates (27). In contrast, our results, which were 
based on a larger number and a wider distribution of both 
cat and human strains and the more discriminatory MST, 
differ from those of these and other authors in that we iden-
tiﬁ  ed 2 lineages (lineages 1 and 4) besides Marseille and 
Houston-1 (18,27). Lineage 1 contained only Asian and 
American strains, which were not included in the study by 
MLST. Lineages Marseille and Houston-1 thus appear to 
be the main phylogenetic organization of B. henselae spe-
cies. However, the phylogenetic organization of B. hense-
lae species, as shown by both MLST and MST, was more 
complex than the structure of 2 main lineages (27,31). The 
4 lineages based on MST provided the most detailed and 
reasonable illustration of the phylogenetic organization of 
B. henselae species because of its ability to show the geo-
graphic distribution of B. henselae. However, more strains, 
especially more human strains of various origin, should be 
studied by using MST to verify and modify this phyloge-
netic organization.
When we compared the MST classiﬁ  cation to classiﬁ  -
cation by 16S rRNA genotypes, we observed that 16SrRNA 
type I strains were restricted to clusters 1 and 2 (Houston-
1), whereas most type II strains were grouped into clusters 
3 (Marseille) and 4. However, a discrepancy between MST 
and 16S rRNA typing was observed within the Houston-1 
cluster. One German cat strain classiﬁ  ed in MST genotype 
22 exhibited the 16S rRNA type II, in contrast to all other 
strains for which the 16S rRNA type was known, includ-
ing other German strains. Such a discrepancy is consistent 
with the ﬁ  ndings of Iredell et al., who demonstrated that 
16S rRNA typing of B. henselae isolates was not entirely 
congruent with their lineage allocations (27).
In conclusion, we demonstrated, with 16 genotypes 
identiﬁ  ed among 75 B. henselae human strains, that MST 
was more discriminatory than previously described meth-
ods for investigating B. henselae infection in humans. We 
did not ﬁ  nd any statistically signiﬁ  cant difference in genet-
ic diversity between human and cat isolates of B. henselae. 
The studied human strains, although geographically lim-
ited, were phylogenetically organized into 2 clusters, which 
matched the origin of cat strains previously described as 
Houston-1 and Marseille clusters. Further studies incor-
porating strains from more diverse geographic origins and 
clinical features will be needed to improve our understand-
ing of the population dynamics of B. henselae. We believe 
that MST can be a valuable tool for this purpose.
Dr Li is a physician and research scientist at  the World 
Health Organization Collaborative Unité des Rickettsies in Mar-
seille, France. His main research interests are the epidemiology 
and genetic diversity of human pathogenic bacteria.
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